NA89
NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
07/21/2023
Back to search
Official data from USPTO
SELCIA
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
SELCIA
ST13
US500000077915471Class
1, 5, 16, 35, 42
Filing
77915471
Registration
4266079
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
55
Latest update
07/21/2023
Trademark type
Word
Nice classes
1, 5, 16, 35, 42
Filing date
01/20/2010
Registration date
01/01/2013
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
07/21/2023
Last transaction
07/21/2023
Responsible office
United States Patent and Trademark Office
Status code
800
Official register
Principal Register
Filing basis
Intent to use, Foreign priority
Drawing code
4
Owner type
03
Owner location
Ongar, Essex, GB
Examiner
LAPTER, ALAIN
Law office
L80
Current location
GENERIC WEB UPDATE
Holders and representatives
Holders
Selcia Limited
Representatives
Rebecca Liebowitz VENABLE LLP
Technical classification
Nice Classes
Class 1Class 5Class 16Class 35Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 1
(Based on 44(e) Syntheticnatural and biological chemicals used in industry and science; syntheticnatural and biological chemicals used in agricultureexcept fungicidesherbicides and parasitides; syntheticnatural and biological chemical compounds for use as radiotracers; radiolabelled chemical compounds for use in regulatoryresearch and scientific studies for research purposes; syntheticnatural and biological chemical compounds with isotopic labels for research purposes; syntheticnatural and biological chemical compounds for research purposes; chemical libraries consisting of chemicals for scientificresearch and development use; chemical fragment libraries consisting of chemicals for scientificresearch and development use; chemical reagents for non-medical purposes; biochemical and biological preparations for use in industryscience and researchexcept for medical use; diagnostic preparations for scientificresearch and development use; radioactive elementsisotopes and preparations for scientificresearch and development usenot including therapeutic or diagnostic use; chemical compoundsnatural products and biologicalschemical compoundsnatural products in the nature of plant and fungal extractscompounds derived from such extracts or plant or fungal derived materialsbiological preparations for use as reference standards of productsimpurities and metabolites in agrochemical and chemical industries
Class 5
(Based on 44(e) Chemical compoundsnatural products and biologicalschemical compoundsnatural products in the nature of plant and fungal extractscompounds derived from such extracts or plant or fungal derived materialsbiological preparations for use as pharmaceuticals for the treatment of infectious diseasesdiseases and disorders in the field of oncologyhepatologynephrologycardiovascularvascularrespiratoryserologyimmunologyhaematologymetabolismneurology and neurodegenerationneuropathiespaingastrointestinaldermatologymuscoskeletalcentral nervous systemendocrinologyhormonalpsychiatricdementiaurologyobstetrics and gynaecologyophthalmologyinflammationodontologydentistrycognitiongenetic disorderscerebrovasculareating disordershearinghypothalamic and pituitary diseasessleep disorders; chemical compoundsnatural products and biologicalschemical compoundsnatural products in the nature of plant and fungal extractscompounds derived from such extracts or plant or fungal derived materialsbiological preparations for use in pharmaceutical research and drug discovery; chemical compoundsnatural products and biologicalschemical compoundsnatural products in the nature of plant and fungal extractscompounds derived from such extracts or plant or fungal derived materialsbiological preparationsbeing clinical candidates for use in pharmaceutical research and drug discovery; chemical compoundsnatural products and biologicalschemical compoundsnatural products in the nature of plant and fungal extractscompounds derived from such extracts or plant or fungal derived materialsbiological preparations for use in hit identificationlead generationoptimisation and development in pharmaceutical research; diagnostic agentspreparations and substances for medical purposes; radiolabelled ligands and isotopically labelled compounds used in screening and diagnostic tests for medical purposes; chemical compoundsnatural products and biologicalschemical compoundsnatural products in the nature of plant and fungal extractscompounds derived from such extracts or plant or fungal derived materialsbiological preparations for use as reference standards of productsimpurities and metabolites in pharmaceutical and veterinary industries
Class 16
(Based on 44(e) Printed matterleafletsbrochureslabelsbookletsmanualsmagazinesbooksguidespamphletscataloguesjournalsnewslettersarticlesreportspromotional literature and product guides in the field of scienceincluding chemistry and biologyin the field of pharmaceuticalmedicinalpesticidalchemical and laboratory research and development services; presentations in the nature of graphic slides and manuals in the field of scienceincluding chemistry and biologyin the field of pharmaceuticalmedicinalpesticidalchemical and laboratory research and development services; printed reports and certificates in the field of pharmaceutical research and developmentcrop protection and environmental regulatory submissions
Class 35
(Based on 44(e) Services in the provision of chemical and biological compounds for use in researchdevelopment and regulatory studieswholesale distributorship services of chemical compounds; stock managementin the nature of inventory management of chemical compounds
Class 42
(Based on 44(e) Scientific research and development servicesscientific design services in the field of chemical and biological preparationtestingresearch and development; scientific consultancy services in the field of chemistry and biology; medicinal chemistry researchdevelopment and consultation services; pharmaceutical research services; chemistry researchdevelopment and consultation services; synthetic chemistry researchdevelopment and consultation services; analytical chemistry researchdevelopment and consultation services; natural products chemistry researchdevelopment and consultation services; chemical and biological laboratory services; analysis in the field of good laboratory practice; biology researchdevelopment and consultation services; cell biology researchdevelopment and consultation services; biology researchdevelopment and consultation services in lead discovery and optimisation; consultancy services in the field of drug discovery and evaluation; researchdevelopment and consultation services in the field of radiolabelling; consultancy services in the field of radiolabelling and radiosynthesis; synthesis and analysis of radiolabelled compounds; researchdevelopment and consultation services in the field of stable labelling; researchdevelopment and consultation services in the field of fragment based drug discoveryfragment screening and fragment based lead discovery; synthesis and analysis of chemical compounds; provision of analytical chemistry and biology services to support regulatory submissions; provision of certification and analysis of the goods and services of others for regulatory submissions; nuclear magnetic resonance spectroscopy for researchdevelopment and laboratory purposes; nuclear magnetic resonance spectroscopy for researchdevelopment and laboratory purposes; researchdevelopment and consultation services in the field of metabolite synthesis; chemistry and biology servicessynthesis of reference standardsprocess impurities and metabolites; analysisresearch and investigation into chemical compounds; analysisresearch and investigation into structural elucidationmetabolite identification and spectral interpretation; anti-counterfeiting services for chemical compoundsanalysis of chemical and biological compounds for purity measurement; preparation of expert reports and interpretation in the field of chemistrybiology and chemical analysis; services in the provision of information and reports in the field of chemistrybiology and chemical analysis for use in researchdevelopment and regulatory studies; scientific data interpretation services; scientific investigationresearchdevelopment and analysis in the fields of pharmaceuticalsbiotechnologystructural biologyveterinaryanimal healthagriculturepesticidesinsecticidesfungicidesherbicidesbiocidesfood and nutritionhouseholdpersonal carecosmetics and the chemical industry; chemical and biological fragment screening technology researchdevelopment and consultation services; electrophoresis researchdevelopment and consultation services; capillary electrophoresis researchdevelopment and consultation services; chemical and biological screening services for researchdevelopment and consultation purposes; fragment based chemical and biological screening services for researchdevelopment and consultation purposes; services in the provision of a chemical fragment librarychemical information and materialsresearch and development servicesprovided to research laboratories of others for the design and development of chemical and biological compounds and pharmaceuticals; screening servicesdevelopment of chemical and biological screenscell biology and protein expression for research and development purposes; adaptation of technology for the provision of screening data and information; provision of information and data in the field of pharmaceutical research and development; consultancy services in the field of the creationgeneration and preparation of research proposals in the field of industrial and scientific research and development; provision of medical chemistry and biology research support; technical support servicesproviding technical advice; provision of information in the fields of scientific research and designchemical compoundsmedical researchmedicinal chemistrypharmaceutical researchchemistrysynthetic chemistryanalytical chemistrybiologychemical and biological screening and analysis; provision of reports on good scientificresearch and development laboratory practice; computational chemistry researchdevelopment and consultation services; informatics serviceschemistry and biology informatics and molecular informatics servicesdata analysis and interpretation; combinatorial chemistry researchdevelopment and consultation services; consultancy in relation to all the aforesaid services
Publications
History of USPTO decisions and trademark events.
55 publications found
RNL1
REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
07/21/2023
89AG
REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
07/21/2023
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
07/21/2023
E89R
TEAS SECTION 8 & 9 RECEIVED
01/03/2023
REM2
COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
01/01/2022
NAS8
NOTICE OF ACCEPTANCE OF SEC. 8 - E-MAILED
01/14/2019
8.OK
REGISTERED - SEC. 8 (6-YR) ACCEPTED
01/14/2019
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
01/14/2019
ES8R
TEAS SECTION 8 RECEIVED
12/24/2018
REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
01/01/2018
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
01/10/2017
COC.
CORRECTION UNDER SECTION 7 - PROCESSED
05/04/2013
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
02/01/2013
ES7R
TEAS SECTION 7 REQUEST RECEIVED
01/24/2013
R.PR
REGISTERED-PRINCIPAL REGISTER
01/01/2013
PUBO
PUBLISHED FOR OPPOSITION
10/16/2012
NPUB
NOTICE OF PUBLICATION
09/26/2012
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
09/07/2012
CNEA
EXAMINERS AMENDMENT MAILED
08/30/2012
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
08/29/2012
XAEC
EXAMINER'S AMENDMENT ENTERED
08/29/2012
CNEA
EXAMINERS AMENDMENT -WRITTEN
08/29/2012
ZZZX
PREVIOUS ALLOWANCE COUNT WITHDRAWN
08/29/2012
PBCR
WITHDRAWN FROM PUB - OG REVIEW QUERY
08/19/2012
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
08/07/2012
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
08/03/2012
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
08/02/2012
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
08/02/2012
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
07/23/2012
CNRT
NON-FINAL ACTION MAILED
02/07/2012
CNRT
NON-FINAL ACTION WRITTEN
02/07/2012
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
02/06/2012
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
02/06/2012
ERFR
TEAS REQUEST FOR RECONSIDERATION RECEIVED
01/13/2012
CNFR
FINAL REFUSAL MAILED
01/05/2012
CNFR
FINAL REFUSAL WRITTEN
01/05/2012
DOCK
ASSIGNED TO EXAMINER
12/22/2011
ACEC
AMENDMENT FROM APPLICANT ENTERED
12/07/2011
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
12/07/2011
PAPER RECEIVED
11/22/2011
CNSI
INQUIRY AS TO SUSPENSION MAILED
05/23/2011
CNSI
SUSPENSION INQUIRY WRITTEN
05/23/2011
RCCK
SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
05/05/2011
ALIE
ASSIGNED TO LIE
05/02/2011
CNSL
LETTER OF SUSPENSION MAILED
11/01/2010
CNSL
SUSPENSION LETTER WRITTEN
11/01/2010
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
10/25/2010
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
10/25/2010
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
10/25/2010
CNRT
NON-FINAL ACTION MAILED
04/26/2010
CNRT
NON-FINAL ACTION WRITTEN
04/26/2010
DOCK
ASSIGNED TO EXAMINER
04/19/2010
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
01/25/2010
NWAP
NEW APPLICATION ENTERED
01/23/2010
Continuous trademark protection
Get notified about every new filing that threatens SELCIA or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.